Current Hypertension Reports

Web alert

Good News and Bad News: First the Good News

Norman M. Kaplan

Good News and Bad News: Now the Bad News

Treatment of hypertension in various racial subgroups

Donald G. Vidt

Antihypertensive drugs and incidence of type 2 diabetes: Evidence and implications for clinical practice

Samuel Asfaha, Raj Padwal

Treatment of resistant hypertension

Sandra J. Taler

Management of hypertension in overweight and obese patients: A practical guide for clinicians

Francesco Dentali, Arya M. Sharma, James D. Douketis

HMG-CoA reductase inhibitors and the kidney

Vito M. Campese, Bassel Hadaya, Josephine Chiu

The role of aldosterone antagonists in the management of resistant hypertension

Mari K. Nishizaka, David A. Calhoun

Hypertension in pregnancy

Maryann Mugo, Gurushankar Govindarajan, L. Romayne Kurukulasuriya, James R. Sowers, Samy I. McFarlane

Proteinuria and Blood Pressure Reduction:

George Bakris

Combination Drug Treatment for Hypertension

Should the target for blood pressure control specify both a systolic and a diastolic component?

Christopher J. Hebert, Ganesh Shidham, Lee A. Hebert

The African American Study of Kidney Disease: Do these results indicate that 140/90 mm Hg is good enough?

Mahboob Rahman, Ashraf El-Meanawy, Joseph Romanello

Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention

Kenneth L. Choi, William J. Elliott

Proteinuria reduction: Mandatory consideration or option when selecting an antihypertensive agent?

Robert D. Toto

Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk?

Stephan J. L. Bakker, Ron T. Gansevoort, Erik M. Stuveling, Rijk O. B. Gans, Dick de Zeeuw

Does dietary salt increase the risk for progression of kidney disease?

Shiraz I. Mishra, Charlotte Jones-Burton, Jeffrey C. Fink, Jeanine Brown, George L. Bakris, Matthew R. Weir